We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRDS
3676
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$23K ﹤0.01%
7,747
+6,354
+456% +$38.8K
MIC
3677
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$23K ﹤0.01%
5,706
-49,177
-90% -$186K
AGM.A icon
3678
Federal Agricultural Mortgage Class A
AGM.A
$1.79B
$22K ﹤0.01%
244
+225
+1,184% +$22.4K
ALGS icon
3679
Aligos Therapeutics
ALGS
$42.3M
$22K ﹤0.01%
746
+550
+281% +$18.7K
ALKT icon
3680
Alkami Technology
ALKT
$2.22B
$22K ﹤0.01%
1,605
-11,912
-88% -$151K
AMRX icon
3681
Amneal Pharmaceuticals
AMRX
$6.02B
$22K ﹤0.01%
6,878
+4,529
+193% +$16.4K
ANIK icon
3682
Anika Therapeutics
ANIK
$283M
$22K ﹤0.01%
993
-1,063
-52% -$23.7K
BBSI icon
3683
Barrett Business Services
BBSI
$800M
$22K ﹤0.01%
1,212
+736
+155% +$13.5K
BV icon
3684
BrightView Holdings
BV
$1.08B
$22K ﹤0.01%
1,801
-6,672
-79% -$83.6K
CTBI icon
3685
Community Trust Bancorp
CTBI
$1.44B
$22K ﹤0.01%
554
+338
+156% +$13.8K
DX
3686
Dynex Capital
DX
$3.23B
$22K ﹤0.01%
1,413
-8,779
-86% -$139K
EPM icon
3687
Evolution Petroleum
EPM
$135M
$22K ﹤0.01%
4,095
-1,513
-27% -$10.2K
HYPD
3688
Hyperion DeFi Inc
HYPD
$42.9M
$22K ﹤0.01%
142
+116
+446% +$21.2K
FISI icon
3689
Financial Institutions
FISI
$825M
$22K ﹤0.01%
840
-7,799
-90% -$217K
FRBA icon
3690
First Bank
FRBA
$471M
$22K ﹤0.01%
1,582
+1,367
+636% +$19.3K
HSII
3691
DELISTED
Heidrick & Struggles
HSII
$22K ﹤0.01%
679
+191
+39% +$6.56K
HY icon
3692
Hyster-Yale Materials Handling
HY
$617M
$22K ﹤0.01%
691
+530
+329% +$18K
IBRX icon
3693
ImmunityBio
IBRX
$8.11B
$22K ﹤0.01%
5,778
-33,077
-85% -$133K
IMVT icon
3694
Immunovant
IMVT
$8.64B
$22K ﹤0.01%
5,760
-4,670
-45% -$20.2K
INNV icon
3695
InnovAge Holding
INNV
$1.45B
$22K ﹤0.01%
5,101
+3,774
+284% +$19.7K
NGS icon
3696
Natural Gas Services Group
NGS
$474M
$22K ﹤0.01%
2,023
+686
+51% +$8.76K
NODK icon
3697
NI Holdings
NODK
$313M
$22K ﹤0.01%
1,358
-3,723
-73% -$61.7K
OLP
3698
One Liberty Properties
OLP
$537M
$22K ﹤0.01%
840
-1,374
-62% -$38.1K
ONDS icon
3699
Ondas Inc
ONDS
$5.08B
$22K ﹤0.01%
4,130
+3,598
+676% +$24.9K
PCB icon
3700
PCB Bancorp
PCB
$400M
$22K ﹤0.01%
+1,156
New +$23.5K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.